Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03995927 · ClinicalTrials.gov registry record
Palliative Radiation Oncology Chief's Clinic
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- 15
- Enrollment target
NCT03995927: Clinical Trial study, sponsored by Wake Forest University Health Sciences.
NCT03995927 is a clinical trial that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03995927 was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The proposed study represents a quality improvement study of a recently-developed dedicated radiation oncology subspecialty clinic with the goal of improving timeliness of palliative radiation therapy and improving resident training in palliative care topics. The aim of this study is to evaluate the impact of this clinic on time to palliative radiation therapy following referral.
Primary Outcome
Number of days between referral to palliative radiation therapy interval and start of palliative radiation therapy compared to historical control. Mean time from referral to the start of RT (measured in days) will be computed for our sample and compared to the historical control mean of 13.4 days using a two-sided one-sample t-test.
Interventions
- OTHER Quality of Life Questionnaire
- OTHER Data collection and analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2019-07-15 |
| Est. Completion | 2020-04-05 |
Why NCT03995927 stopped before completion
NCT03995927 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Quality of Life Questionnaire is the first listed.
NCT03995927 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03995927 about?
NCT03995927 is a clinical study titled "Palliative Radiation Oncology Chief's Clinic". The proposed study represents a quality improvement study of a recently-developed dedicated radiation oncology subspecialty clinic with the goal of improving timeliness of palliative radiation therapy and improving resident training in palliative care topics. The aim of this study is to evaluate the...
What is the current status of trial NCT03995927?
This trial is currently terminated. The enrollment target is 15 participants. The study started on 2019-07-15. Estimated completion is 2020-04-05.
What interventions are being tested in trial NCT03995927?
The interventions under investigation include: Quality of Life Questionnaire (OTHER), Data collection and analysis (OTHER).
Who is sponsoring clinical trial NCT03995927?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI